Structure | Chemical Name | CAS | MF |
|
PROSTAGLANDIN VIII
|
|
C15H26O4
|
|
Prosta-5,11-dien-1-oic acid, 9-(methoxyimino)-11,15-bis[(trimethylsily l)oxy]-, (5Z,8beta,9E,11alpha,13E,15S)-
|
39003-26-4
|
C30H59NO5Si3
|
|
Prosta-Capsules
|
81278-84-4
|
|
|
prostaglandin D2 receptor
|
|
|
|
ProstateSpecificAntigen(Psa)ActComplex>95%Pure
|
|
|
|
prostaglandin E2 azidophenacyl ester
|
129163-95-7
|
C28H37N3O6
|
|
prostaglandin F2alpha N-dimethylamide
|
67508-08-1
|
C22H39NO4
|
|
prostein
|
|
|
|
prostate stromal protein, 20 kDa
|
|
|
|
PROSTATICACIDPHOSPHATASE(PSAP),CLONE:PASE/4LJ,MABANTI-HUMAN
|
|
|
|
Prostaglandins G
|
|
|
|
prostacyclin synthesis stimulating plasma factor
|
|
|
|
Prostaglandins, Synthetic
|
|
|
|
PROSTATESPECIFICANTIGEN(PSA),FREE,RABBITANTI-HUMAN,ELISAKIT
|
|
|
|
Δ7-Prostaglandin A1
|
|
|
|
PROSTATICACIDPHOSPHATASE(PAP),GOATANTI-HUMAN
|
|
|
|
Prostaglandins E
|
|
|
|
PROSTAGLANDIN BX
|
39306-29-1
|
C20H32O4
|
|
prostate carcinoma tumor antigen
|
|
|
|
prostasin
|
|
|
|
PROSTAGLANDIN E2-BIOTINIMIDE
|
|
C35H58N4O6S
|
|
PROSTATICINHIBINPEPTIDE,CLONE:4A6A6,MABANTI-HUMAN:PARAFFIN,IH
|
|
|
|
prostaglandin E2 methyl oxime
|
86659-90-7
|
C21H35NO5
|
|
PROSTATESPECIFICANTIGEN(PSA),FREE,ELISAKIT
|
|
|
|
prostaglandin F2alpha 15-methyl ether
|
40834-96-6
|
C21H36O5
|
|
PROSTATE SUBSTANCE
|
|
|
|
PROSTAGLANDIN F3ALPHA
|
745-64-2
|
C20H32O5
|
|
Prostaglandin Antagonists
|
|
|
|
prostaglandin I2 15-methyl ether
|
79743-29-6
|
C21H34O5
|
|
PROSTAGLANDIN D2, [5,6,8,9,12,14,15-3H]
|
|
C20H25O5T7
|
|
PROSTAGLANDIN F2ALPHA LIPID MAPS
|
|
|
|
PROSTAGLANDINS I2 METHYL ESTER
|
61799-74-4
|
C21H34O5
|
|
PROSTAGLANDIN I SYNTHASE (MURINE) BLOCKING PEPTIDE
|
|
|
|
PROSTAGLANDIN I SYNTHASE BLOCKING PEPTIDE
|
|
C144H246N38O47S
|
|
Prostaglandin H Synthase-2, Human, Recomb.
|
|
|
|
PROSTAGLANDIN F2ALPHA ETHANOLAMIDE LIPID MAPS
|
|
|
|
Prost-13-ene-1,20-dioic acid, 15-hydroxy-16,16-dimethyl-9-(tetrahydro-2H-pyran-2-yl)oxy-, 1-methyl 20-(1-methylethyl) ester, (13E)-(+-)-
|
68624-50-0
|
|
|
prostaglandin EP4 receptor
|
|
|
|
prostaglandylinositol cyclic phosphate synthetase
|
|
|
|
prostaglandin-inositol cyclic phosphate
|
|
|
|
ProstateShort-ChainDehydrogenase-Reductase1(Psdr1)
|
|
|
|
PROSTATESPECIFICMEMBRANEANTIGEN(PSMA),MABANTI-HUMAN:PARAFFIN,IHC
|
|
|
|
PROSTATECANCER
|
|
|
|
ProstateSpecificAntigen(Psa)ActComplex>99%Pure
|
|
|
|
Prostaglandins F, Synthetic
|
|
|
|
(+-)-Prostaglandin E1
|
20348-58-7
|
C20H34O5
|
|
Prostatic Acid Phosphatase ELISA
|
|
|
|
PROSTAGLANDIN F1ALPHA
|
745-62-0
|
C20H36O5
|
|
ProstateSpecificAntigen(Psa)>90%Pure
|
|
|
|
PROSTAGLANDIN TRANSPORTER BLOCKING PEPTIDE
|
|
|
|
Prostaglandin E4
|
|
|
|
PROSTATICACIDPHOSPHATASE(PSAP),CLONE:4LJ,MABANTI-HUMAN
|
|
|
|
PROSTAGLANDIN G2
|
51982-36-6
|
C20H32O6
|
|
prostaglandin-E2 9-reductase
|
|
|
|
PROSTAGLANDIN D2 ETHANOLAMIDE LIPID MAPS
|
|
|
|
Prost-13-en-1-oic acid, 5,6,9,11,15-pentahydroxy-, (9alpha,11alpha,13E ,15S)-
|
87692-41-9
|
|
|
PROSTATESPECIFICANTIGEN(PSA),ELISAKIT
|
|
|
|
prostaglandin E0
|
|
|
|
prostaglandin R2 D-isomerase
|
|
|
|
prostate short-chain dehydrogenase reductase 1
|
|
|
|
prostaglandin H2 receptor
|
|
|
|
prostaglandin D2 methyl ester
|
49852-81-5
|
C21H34O5
|
|
Prostein,C-Terminal&N-Terminal
|
|
|
|
PROSTAGLANDIN G1
|
52162-11-5
|
C20H34O6
|
|
ProstaglandinE1-γ-cyclodextrin complex
|
|
|
|
Prosulfuron Solution
|
|
|
|
Prosulfocarb PESTANAL
|
|
|
|
[Pro9]substance P sulfone
|
|
|
|
prosulpride
|
68556-59-2
|
C16H25N3O4S
|
|
Prosultiamine
|
59-58-5
|
C15H24N4O2S2
|
|
PRO-SUMO-3 (HUMAN)
|
|
|
|
prosubtilisin
|
117444-15-2
|
|
|
PROSULFOCARB
|
52888-80-9
|
C14H21NOS
|
|
prosurugatoxin
|
99102-40-6
|
C25H26BrN5O11
|
|
Prosulfuron
|
94125-34-5
|
C15H16F3N5O4S
|
|
PRO-SUMO 2 (HUMAN)
|
|
|
|
PSFK-1 CELL LYSATE
|
|
|
|
Pseudin-2
|
388602-02-6
|
C122H202N36O32
|
|
PSEUDOCUMENE-5-SULFONIC ACID
|
3453-84-7
|
C9H12O3S
|
|
Pseudolaric Acid C
|
82601-41-0
|
C21H26O7
|
|
Pseudolaric acid B-O-β-D-glucopyranoside
|
|
|
|
Pseudolaric acid A-O-β-D-glucopyranoside
|
|
|
|
Pseudoindorin
|
75514-30-6
|
C15H12O5
|
|
Pseudouridine 5’-Triphosphate
|
1175-34-4
|
C9H15N2O15P3
|
|
Pseudo Codeine Hydrochloride
|
102043-42-5
|
C18H22ClNO3
|
|
Pseudolaric acid D
|
115028-67-6
|
C20H30O3
|
|
pseudomonas Agar Ba
|
|
|
|
PseudoMonic Acid D SodiuM
|
85178-60-5
|
C26H41NaO9
|
|
Pseudoephedroxane-d3
|
|
C11H13NO2
|
|
Pseudoephedrine-d3
|
754966-06-8
|
C10H15NO
|
|
Pseudolaric acid B-glucopyranoside
|
98891-41-9
|
C29H38O13
|
|
Pseudolaric Acid A-O-beta-D-glucopyranoside
|
98891-44-2
|
C28H38O11
|
|
Pseudolaric acid B-O-beta-D-glucopyranoside
|
|
|
|
Pseudoanguillosporin A
|
1159392-22-9
|
C17H26O3
|
|
Pseudo Acarbose
|
196944-81-7
|
C25H43NO17
|
|
pseudorabies virus immediate early proteins
|
|
|
|
Pseudomonas syringae, strain 742 RS
|
68602-93-7
|
|
|
PSEUDOMONASAERUGINOSA,GROUPK,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
PSEUDO LINALYL ACETATE
|
69103-01-1
|
C12H20O2
|
|
pseudovitamin B12
|
13408-75-8
|
C59H83CoN17O14P
|